Acepodia, Inc. (TPEX:6976)
Taiwan
· Delayed Price · Currency is TWD 18.40
-0.10 (-0.54%)
May 21, 2025, 2:59 PM CST
Acepodia Revenue
In the year 2024, Acepodia had annual revenue of 427.00K TWD, down -97.43%. Acepodia had revenue of 116.00K in the half year ending December 31, 2024.
Revenue
427.00K
Revenue Growth
-97.43%
P/S Ratio
24,720.48
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 427.00K | -16.17M | -97.43% |
| Dec 31, 2023 | 16.59M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 87.67M |
| Oneness Biotech | 117.33M |
| Center Laboratories | 1.63B |
| Pegavision | 6.69B |